Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock

British Journal of Pharmacology

Volumn 119, Issue 1, 1996, Pages 23-28

  Squadrito, Francesco ^a   Altavilla, Domenica ^a   Squadrito, Giovanni ^a   Campo, Giuseppe M ^a   Ioculano, Mariapatrizia ^a   Canale, Patrizia ^a   Rossi, Francesco ^b   Saitta, Antonino ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Nitric oxide donor; Nitric oxide synthase inhibition; SAO shock

Indexed keywords

ACETYLCHOLINE; C87 3754; MYELOPEROXIDASE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; HYPOTENSION; ILEUM; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW; SURVIVAL RATE; SURVIVAL TIME;

EID: 0029790926     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15672.x     Document Type: Article

References (28)

1. AOKI, N., JOHNSON III, G. & LEFER, A.M. (1990). Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am. Physiol. Soc., 321, G275-G281.
2. BUSSE, R. & MULSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 87-90.
3. CANALE, P., SQUADRITO, F., ALTAVILLA, D., IOCULANO, M., ZINGARELLI, P., CAMPO, G.M., URNA, G., SARDELLA, A., SQUADRITO, G. & CAPUTI, A.P. (1994). TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. Agents Actions, 42, 128-134.
4. CAPUTI, A.P., ROSSI, F., CARNEY, K. & BREZENOFF, H.E. (1980). Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther., 215, 309-316.
5. CAREY, C., SIEGFRIED, M.R., MA, X., WEYRICH, A.S. & LEFER, A.M. (1992). Antishock and endothelial protective actions of a NO donor in mesenteric ischaemia and reperfusion. Circ. Shock, 38, 209-216.
6. DAWSON, V.M., DAWSON, T.M., LONDON, E.D., BRET, D.S. & SNYDER, S.H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 88, 6368-6371.
7. DINERMAN, J.L., LOWENSTEIN, C.J. & SNYDER, S.H. (1993). Molecular mechanisms of nitric oxide production. Potential relevance to cardiovascular disease. Circ. Res., 73, 217-222.
8. GROSS, S.S., STUEHR, D.J., AISAKA, K., JAFFE, E.A., LEVI, R. & GRIFFITH, O.W. (1990). Macrophages and endothelial cell nitricoxide synthesis: cell-type selective inhibition by N-aminoarginine, N-nitroarginine and N-methylarginine. Biochem. Biophys. Res. Commun., 170, 96-103.
9. HASAN, K., HEESEN, B.J., MCDANIEL, M.L., CHANG, K., ALLISON, W., WOLFFENBUTTEL, B.H.R., WILLIAMSON, J.R. & TILTON, R.G. (1993). Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol., 249, 101 106.
10. JULOU-SCHAEFFER, G., GRAY, G.A., FLEMMING, G.I., SCHOTT, C.C., PARATT, J.R. & STOCLET, J.S. (1991). Activation of the L-arginine/nitric oxide pathway is involved in vascular hyporeactivity induced by endotoxin. J. Cardiovasc. Pharmacol., 17, S207-S212.
11. KLEMM, P., THIEMERMANN, C., WINKLMAIER, G., MARTORANA, P.A. & HENNING, R. (1995). Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br. J. Pharmacol., 114, 363-368.
12. LEFER, A.M. & LEFER, D.J. (1994). Therapeutic role of nitric oxide donors in the treatment of cardiovascular disease. Drugs of the Future, 19, 665-672.
13. MARLETTA, M.A. (1993). Nitric oxide synthase structure and mechanism. J. Biol. Chem., 268, 1231-1234.
14. MISKO, T.P., MOORE, W.M., KASTEN, T.P., NICKOLS, D.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
15. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
16. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FABES J., 6, 3051-3064.
17. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
18. PALMER, R.M.J., REES, D.D., ASHTON, D.S. & MONCADA, S. (1988). L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 153, 1251-56.
19. SOUTHAN, G.J., SZABO, C & THIEMERMANN, C. (1995). Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol., 114, 510 516.
20. SQUADRITO, F., ALTAVILLA, D., CANALE, P., IOCULANO, M., CAMPO, G.M., AMMENDOLIA, L., FERLITO, M., ZINGARELLI, B., SQUADRITO, G., SAITTA, A. & CAPUTI, A.P. (1994). Participation of tumor necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br. J. Pharmacol., 113, 1153 1159.
21. 2 receptor antagonist, in splanchnic artery occlusion shock. J. Cardiovasc. Pharmacol., 19, 115-119.
22. SQUADRITO, K., ALTAVILLA, D., ZINGARELLI, B., IOCULANO, M., CALAPAI, G., CAMPO, G.M., MICELI, A. & CAPUTI, A.P. (1993). Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur. J. Pharmacol., 237, 223-230.
23. SQUADRITO, F., STURNIOLO, R., ALTAVILLA, D., SANTORO, G., CAMPO, G.M., ARENA, A. & CAPUTI, A.P. (1991). Platelet activating factor involvement in splanchnic artery occlusion shock in rats. Eur. J. Pharmacol., 192, 47-53.
24. SZABO, C., SOUTHAN, G.J. & THIEMERMANN, C. (1994). Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A., 91, 12472-12476.
25. THIEMERMANN, C. SZABO, C., MITCHELL, J.A. & VANE, J.R. (1993). Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 90, 267-271.
26. THIEMERMANN, C., RUTTEN, H., WU, C.C. & VANE, J.R. (1995). The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol., 116, 2845 2851.
27. VANE, J.R., ANGGARD, E.E. & BOTTING, R.M. (1990). Regulatory functions of the vascular endothelium. N. Engl. J. Med., 323, 21-36.
28. VANE, J.R. (1994). The Croonian lecture, 1993: The endothelium: maestro of the blood circulation. Proc. R. Soc. B., 343, 225-246.